(Updated - April 16, 2026 6:40 AM EDT)

Oppenheimer analyst Jeff Jones initiates coverage on Aclaris Therapeutis (NASDAQ: ACRS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE